Literature DB >> 20817486

Chemerin: at the crossroads of inflammation and obesity.

Matthew C Ernst1, Christopher J Sinal.   

Abstract

Chemerin is a secreted protein with a complex but well-established role in immune function. Parallel lines of investigation also support the notion that chemerin is a novel adipokine that regulates adipocyte development and metabolic function as well as glucose metabolism in liver and skeletal muscle tissues. A growing body of human experimental data indicates that serum chemerin levels are elevated in patients with obesity and that they exhibit a positive correlation with various aspects of the metabolic syndrome. Thus, the dual role of chemerin in inflammation and metabolism might provide a link between chronic inflammation and obesity, as well as obesity-related disorders such as type 2 diabetes and cardiovascular disease.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20817486     DOI: 10.1016/j.tem.2010.08.001

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  130 in total

1.  Chemerin158K protein is the dominant chemerin isoform in synovial and cerebrospinal fluids but not in plasma.

Authors:  Lei Zhao; Yasuto Yamaguchi; Shadi Sharif; Xiao-Yan Du; Jason J Song; David M Lee; Lawrence D Recht; William H Robinson; John Morser; Lawrence L K Leung
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

2.  Chemerin receptor blockade improves vascular function in diabetic obese mice via redox-sensitive and Akt-dependent pathways.

Authors:  Karla Bianca Neves; Aurelie Nguyen Dinh Cat; Rheure Alves-Lopes; Katie Yates Harvey; Rafael Menezes da Costa; Nubia Souza Lobato; Augusto Cesar Montezano; Ana Maria de Oliveira; Rhian M Touyz; Rita C Tostes
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-09-14       Impact factor: 4.733

3.  Exercise-induced lowering of chemerin is associated with reduced cardiometabolic risk and glucose-stimulated insulin secretion in older adults.

Authors:  S K Malin; S D Navaneethan; A Mulya; H Huang; J P Kirwan
Journal:  J Nutr Health Aging       Date:  2014       Impact factor: 4.075

4.  Association of serum chemerin levels with the severity of coronary artery disease in patients with metabolic syndrome.

Authors:  Gökhan Aksan; Sinan İnci; Gökay Nar; Korhan Soylu; Ömer Gedikli; Serkan Yüksel; Metin Özdemir; Rukiye Nar; Murat Meriç; Mahmut Şahin
Journal:  Int J Clin Exp Med       Date:  2014-12-08

5.  Impact of OSA on biological markers in morbid obesity and metabolic syndrome.

Authors:  Neus Salord; Mercè Gasa; Mercedes Mayos; Ana Maria Fortuna-Gutierrez; Josep Maria Montserrat; Manuel Sánchez-de-la-Torre; Antonia Barceló; Ferran Barbé; Núria Vilarrasa; Carmen Monasterio
Journal:  J Clin Sleep Med       Date:  2014-03-15       Impact factor: 4.062

6.  Proteolytic cleavage of chemerin protein is necessary for activation to the active form, Chem157S, which functions as a signaling molecule in glioblastoma.

Authors:  Yasuto Yamaguchi; Xiao-Yan Du; Lei Zhao; John Morser; Lawrence L K Leung
Journal:  J Biol Chem       Date:  2011-09-23       Impact factor: 5.157

7.  Role of chemerin/CMKLR1 in the maintenance of early pregnancy.

Authors:  Xuezhou Yang; Junning Yao; Qipeng Wei; Jinhai Ye; Xiaofang Yin; Xiaozhen Quan; Yanli Lan; Hui Xing
Journal:  Front Med       Date:  2018-03-17       Impact factor: 4.592

Review 8.  Adipokines as a novel link between obesity and atherosclerosis.

Authors:  Hye Jin Yoo; Kyung Mook Choi
Journal:  World J Diabetes       Date:  2014-06-15

9.  The chemerin knockout rat reveals chemerin dependence in female, but not male, experimental hypertension.

Authors:  Stephanie W Watts; Emma S Darios; Adam E Mullick; Hannah Garver; Thomas L Saunders; Elizabeth D Hughes; Wanda E Filipiak; Michael G Zeidler; Nichole McMullen; Christopher J Sinal; Ramya K Kumar; David J Ferland; Gregory D Fink
Journal:  FASEB J       Date:  2018-06-15       Impact factor: 5.191

10.  Development of a membrane-anchored chemerin receptor agonist as a novel modulator of allergic airway inflammation and neuropathic pain.

Authors:  Jamie R Doyle; Subrahmanian T Krishnaji; Guangli Zhu; Zhen-Zhong Xu; Daniel Heller; Ru-Rong Ji; Bruce D Levy; Krishna Kumar; Alan S Kopin
Journal:  J Biol Chem       Date:  2014-03-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.